Nature Reviews Cancer – In this Journal Club, Chae and Chung discuss a study characterizing the differentiation and maturation of both tumour-resident and circulating B cells in patients with…
Treatment options after progression on anti–PD-1 and BRAF/MEK inhibitors have been limited but TIL therapy has expanded metastatic melanoma treatment.
Of 22 pesticides associated with prostate cancer incidence, 4 were also associated with prostate cancer death.
Nature Biotechnology – Single-cell, multiomic datasets are integrated using dimensionality reduction, imputation and batch correction.
Sarah Sammons, MD, discusses findings from an analysis of the DESTINY-Breast03 trial regarding trastuzumab deruxtecan vs trastuzumab emtansine in the context of HER2-positive breast cancer…
The FDA has received an NDA seeking the approval of a 3-month formulation of leuprolide mesylate for advanced prostate cancer.
Immunotherapy innovation is a full-time focus at an Ohio State institute where researchers develop new ways to treat cancer with patients’ own natural defenses.
A nurse practitioner discusses the importance of compassionate end-of-life care discussions.
Investigators are examining and implementing several innovations that they hope will combat the persistent issue of limited access to cancer care for patients living in…
Pediatric Research – Standardizing feeding strategies for preterm infants born greater than 1500 grams
